Aurora Non Operating Income Net Other from 2010 to 2025
| ACB Stock | USD 5.05 0.35 7.45% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Aurora Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aurora Cannabis' main balance sheet or income statement drivers, such as Interest Expense of 8 M, Other Operating Expenses of 209.2 M or Operating Income of 5.2 M, as well as many indicators such as Price To Sales Ratio of 0.96, Dividend Yield of 0.0 or PTB Ratio of 0.58. Aurora financial statements analysis is a perfect complement when working with Aurora Cannabis Valuation or Volatility modules.
Aurora | Non Operating Income Net Other | Build AI portfolio with Aurora Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aurora Cannabis offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurora Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurora Cannabis Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurora Cannabis Stock:Check out the analysis of Aurora Cannabis Correlation against competitors. For information on how to trade Aurora Stock refer to our How to Trade Aurora Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurora Cannabis. If investors know Aurora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurora Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.92) | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.343 | Return On Assets |
The market value of Aurora Cannabis is measured differently than its book value, which is the value of Aurora that is recorded on the company's balance sheet. Investors also form their own opinion of Aurora Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Aurora Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurora Cannabis' market value can be influenced by many factors that don't directly affect Aurora Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurora Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurora Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurora Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.